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Abstract
 
T cell receptor interactions with peptide/major histocompatibility complex (pMHC) ligands
control the selection of T cells in the thymus as well as their homeostasis in peripheral lym-
phoid organs. Here we show that pMHC contact modulates the expression of CD5 by naive
CD4 T cells in a process that requires the continued expression of p56
 
lck
 
. Reduced CD5 levels
in T cells deprived of pMHC contact are predictive of elevated Ca
 
2
 

 
 responses to subsequent
TCR engagement by anti-CD3 or nominal antigen. Adaptation to peripheral pMHC contact
may be important for regulating naive CD4 T cell responsiveness.
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Introduction
 
The fate of immature CD4
 

 
CD8
 

 
 double positive thy-
mocytes is controlled by TCR interactions with self-pep-
tide/MHC (pMHC)
 
*
 
 in the thymus. Cells with overtly
self-reactive TCRs are eliminated (negative selection; ref-
erences 1 and 2) and a fraction of moderately self-reactive
cells differentiate to the mature CD4
 

 
 or CD8
 

 
 single pos-
itive (SP) stage (positive selection; references 2 and 3). The
latter undergo a series of preprogrammed events during
which their responsiveness to selecting pMHC ligands is
thought to change (4–7). This involves the regulated ex-
pression of CD5, a putative negative regulator of lympho-
cyte receptor signaling (8–15), and the tyrosine phosphatase
1 (16) which associates inducibly with an immunoreceptor
tyrosine-based inhibitory motif in the cytoplasmic domain
of CD5 (10, 11). Thymocytes (8), mature T cells (12), and
B1 B cells (9) have all been shown to be hyperresponsive to
TCR/BCR signaling in CD5-deficient mice. Although T
cells develop in normal numbers in CD5-deficient mice
(17, 18) the TCR repertoire selected in the thymus is af-
fected both by the absence (8, 12, 18) and the overexpres-
sion of CD5 (14).
High level CD5 expression is an early indicator of TCR
engagement at the double positive stage and associated with
entry into the selection process (2, 14, 15, 19–21). The
precise level of CD5 expressed by TCR transgenic thy-
mocytes is determined by the nature of TCR/pMHC in-
teractions driving thymocyte differentiation to the single
positive stage, with interactions deemed to be ‘stronger’
driving higher levels of expression (14, 15, 20). Reminis-
cent of adaptation events in sensory receptors (22, 23),
pMHC encounter has been shown to alter thymocyte re-
sponsiveness to TCR-mediated signals (15). CD5 levels
were inversely correlated with thymocyte responsiveness in
these experiments (15). These studies have led to proposals
that the developmentally regulated expression of CD5 is
significant for setting TCR response thresholds appropriate
for the spectrum of pMHC complexes encountered by de-
veloping thymocytes and the establishment of tolerance via
the fine-tuning of thymocyte responsiveness to self-pMHC
complexes (14, 15). It has been assumed that CD5 levels
and activation thresholds are set in the thymus ‘once and
for all’ and subsequently maintained by naive peripheral T
cells in the absence of TCR engagement (20). In this view,
sensory adaptation would be limited to pMHC complexes
encountered during thymic selection. However, TCR/
pMHC interactions continue in the periphery, where they
promote the long-term survival (24–29) and/or homeosta-
sis of naive T lymphocytes (30–35). This role of pMHC in
the maintenance of the naive peripheral T cell repertoire,
together with evidence that not all thymic and peripheral
pMHC complexes are the same (36) and data that LN T
cells express more diverse CD5 levels than single positive
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thymocytes (unpublished data and see below) led us to ex-
plore an alternative hypothesis, namely that CD5 levels and
T cell responsiveness may remain adaptable to signals re-
ceived in the periphery. Here we show that CD5 expres-
sion by naive CD4 T cells is regulated by MHC contact.
Interestingly, reduced CD5 levels in T cells deprived of
MHC contact are associated with elevated Ca
 
2
 

 
 responses
to subsequent TCR engagement. Hence, naive CD4 T
cells appear to undergo a process akin to sensory adapta-
tion. In addition, we identify p56
 
lck
 
 as a critical component
of the mechanism by which CD5 expression is adjusted to
reflect TCR/pMHC contact in CD4 T cells.
 
Materials and Methods
 
Cell Culture.
 
Cells from the superficial inguinal, brachial, and
cervical LN of AND TCR transgenic (37) recombinase activat-
ing gene (Rag)1
 
o/o
 
 (38) mice were depleted of MHC class II
(2G9, AF6–120.1, or 14–4-4S), CD11b (M1/70), CD11c (HL3),
and CD16 (2.4G2) expressing cells using biotinylated antibodies
(BD PharMingen) and SA-coated immunomagnetic beads (Dy-
nal) and maintained either in suspension or in reaggregate cul-
tures established as described previously (19) from thymic stromal
cells (prepared by trypsinization of deoxyguanosine-treated fetal
thymi and centrifugation over 55% Percoll; Amersham Pharmacia
Biotech), bone marrow (BM)–derived APCs (obtained by culture
in GM-CSF–containing medium as described previously; refer-
ence 39), and LN cells at a ratio of 3:1:10 on Nucleopore filters
(0.8
 
 
 
m; Costar) floating on IMDM (10% heat inactivated FCS,
2 
 

 
 10
 

 
5
 
 M 2-ME, 50 
 

 
g/ml gentamycin).
 
Flow Cytometry and Cell Sorting.
 
Cells were counted and
stained with CD4-PE (Caltag), -PerCP or -allophycocyanin,
CD5-FITC or -PE, TCR V
 

 
3-FITC or V
 

 
11-FITC,
CD45RB-FITC, CD44-FITC, or CD69-FITC (BD PharMin-
gen) and analyzed on a FACScalibur™ (Becton Dickinson) as de-
scribed previously (19).
For Ca
 
2
 

 
 assays, cultured cells were first incubated for 20 min
at room temperature in PBS, 2mM Ca
 
2
 

 
, 2.5 
 

 
M Fluo-4 a.m.
(Molecular Probes), and CD4-allophycocyanin (BD PharMin-
gen). This was followed (where indicated) by incubation on ice
with the specified dilution of KT3 (anti-CD3
 

 
; reference 40) su-
pernatant titrated to be saturating at 1/56. Samples were analyzed
on a FACScalibur™ (Becton Dickinson) in a 37
 
	
 
C sample jacket
immediately after addition of goat anti–rat Ig (20 
 

 
g/ml final
concentration; Dako). Alternatively, Fluo-4–loaded AND T cells
were mixed 1:1 with B10.BR (H-2
 
k
 
) BM–derived APCs which
where indicated had been pulsed for 2 h with 10 
 

 
g/ml of the
cognate pigeon cytochrome-C peptide 81–104 or the variant
peptides K99R or K99A (41). Samples were acquired for 1–2
min, pelleted for 10 s (13,000 rpm) in a microfuge to provide T
cell/APC contact, and moved back to the flow cytometer. For
Ca
 
2
 

 
 assays ex vivo, LN cells were stained with anti-CD44 (IM7;
BD PharMingen) followed by anti–rat IgG-Cy5 (Caltag), and, af-
ter blocking with rat serum, CD4-PerCP, and CD5-PE (BD
PharMingen). The cells were then loaded with Fluo-4 as above
and analyzed on a FACScalibur™ (Becton Dickinson) in a 37
 
	
 
C
sample jacket immediately after addition of goat anti–rat Ig (20
 

 
g/ml final concentration; Dako). Ca
 
2
 

 
 data were analyzed using
FCSPress software (Ray Hicks, FCSPress, Cambridge, UK).
For the isolation of CD5
 
low
 
 and CD5
 
high
 
 naive-phenotype
CD4 T cells, suspensions of superficial inguinal, brachial, and cer-
vical LNs of specific pathogen free C57BL/10 (H2
 
b
 
) or Balb/c
(H2
 
d
 
) mice were depleted of CD8- and B220-expressing cells
with biotinylated antibodies and SA-coated immunomagnetic
beads (Dynal), stained with CD4-tricolor (Caltag), CD45RB-
FITC or CD44-FITC (BD PharMingen), sorted on a FACSVan-
tage™ (Becton Dickinson), labeled with 1 
 

 
g/ml CFSE (Molec-
ular Probes) for 10 min at room temperature, washed twice in
PBS 0.1% BSA and injected intraveneously (1–4 
 

 
 10
 
6
 
 cells per
mouse) into sublethally (450 rad) irradiated syngeneic or un-
treated Rag1
 
o/o
 
 A
 

 
o/o
 
 
 

 
2m
 
o/o
 
 mice (38, 42, 43), referred to be-
low as Rag1
 
o/o
 
 MHC
 
o/o
 
.
 
Western Blot Analysis.
 
Cell lysates were separated (5 
 

 
 10
 
5
 
–
10
 
6
 
 T cell equivalents per lane) on 12% SDS polyacrylamide gels
and blotted onto PVDF membranes (NEN Life Science Prod-
ucts). Blots were blocked (1% BSA in PBS, 0.1% Tween 20),
probed with the anti-phosphotyrosine mAb 4G10 (1 
 

 
g/ml,
0.1% BSA; Upstate Biotechnology) followed by alkaline phos-
phatase-conjugated goat anti–mouse IgG and enhanced chemolu-
minescence detection (Western Star) on MR-1 film (Kodak).
Blots were stripped (200 mM glycine, 1% Tween-20, 0.1% SDS,
pH 2.2) and reprobed with anti-CD3 
 


 
 (Santa Cruz Biotechnol-
ogy, Inc.).
 
Results
 
Maintenance of CD5 Expression Levels on Naive Periph-
eral CD4 T Cells Requires pMHC Contact.
 
APC-depleted
CD4 LN T cells from unprimed AND TCR transgenic
mice (37) deficient in Rag1 (38) were employed as a near
homogeneous population of naive peripheral T cells with
uniform TCR specificity (37, 41). While CD5 expression
increased dramatically when AND LN cells were cultured
under conditions of TCR engagement (data not shown),
CD5 levels declined to 50% or less of the ex vivo levels
when these cells were cultured for 24 to 48 h in the ab-
sence of TCR stimulation. This downregulation was selec-
tive for CD5 since the expression of CD4 and TCR re-
mained unchanged or increased slightly during the culture
period (Fig. 1 A). CD5 downregulation was accompanied
by a reduction of protein tyrosine phosphorylation relative
to the level in resting T cells freshly isolated ex vivo, in-
cluding p21 phospho-
 


 
 (33, 44; Fig. 1 B).
These data suggest that CD5 expression by peripheral
CD4 T cells requires active maintenance, but they do not
distinguish between a requirement for MHC contact or
other factors (such as lymphokines; references 45 and 46)
encountered in vivo. To discriminate between these possi-
bilities we generated CD4 T cells that had been selected on
different doses of the same pMHC ligands and followed
their CD5 levels after transfer into deficient hosts. CD5
levels on Rag1
 
o/o
 
 AND TCR transgenic CD4 cells re-
flected MHC class II dosage and was higher in A
 

 

 
/
 

 
 mice
than in A
 

 

 
/o
 
 mice (mean fluorescence intensity 119 for
A
 

 

 
/
 

 
 versus 96 for A
 

 

 
/o
 
; 
 
n 
 
 
 
8; see Fig. 2 ex vivo). To
ask whether CD5 levels are stable in vivo in the absence of
MHC class II we adoptively transferred Rag1
 
o/o
 
 AND
CD4 T cells from A
 

 

 
/
 

 
 and A
 

 

 
/o
 
 donors into Rag1
 
o/o
 
MHC
 
o/o
 
 hosts. 3 d after transfer, AND TCR transgenic
CD4 cells showed reduced CD5 expression, but CD5 lev-
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els on cells from A
 

 

 
/
 

 
 and A
 

 

 
/o
 
 donors were still distin-
guishable (Fig. 2, d 3). 5 d after transfer CD5 expression by
both populations was four to fivefold lower than on the day
of transfer (compare Fig. 2 ex vivo and d 5). CD5 down-
regulation was selective (levels of CD4 and the transgenic
TCR were not reduced) and occurred in the absence of
early apoptotic markers as there was no increase in reactive
oxygen species or loss of mitochondrial membrane poten-
tial (reference 47; data not shown). These data demonstrate
that (i) CD5 expression declines on transfer of Rag1
 
o/o
 
AND TCR transgenic CD4 cells into MHC
 
o/o
 
 Rag1
 
o/o
 
hosts and that (ii) the differences in CD5 levels found be-
tween Rag1
 
o/o
 
 AND TCR transgenic CD4 cells selected
on one or two doses of A
 
b
 
 (i.e., in A
 

 

 
/o
 
 and A
 

 

 
/
 

 
 mice,
respectively) disappear on transfer into MHC
 
o/o
 
 Rag1
 
o/o
 
hosts. We conclude that CD5 expression levels in naive pe-
ripheral CD4 T cells reflect continued MHC contact.
 
Continued Expression of p56
 
lck
 
 Is Required for the Mainte-
nance of CD5 Levels by Peripheral CD4 T Cells.
 
To begin
to elucidate the mechanisms that maintain CD5 in periph-
eral CD4 T cells we made use of a recently described
mouse model, Lck1/rtTA-C/lck
 
neg
 
, that allows the regu-
lated expression of p56
 
lck
 
 by reconstituting lck-deficient
mice with a p56
 
lck
 
 transgene under the control of the tetra-
cyclin response element responsive to the reverse tetracy-
clin transactivator (48). lck expression is controlled by ad-
ministration of the tetracycline derivative doxycycline. In
the presence of doxycycline, lck expression in Lck1/rtTA-
C/lck
 
neg
 
 mice is higher than wild-type in the thymus but
lower in peripheral T cells. Withdrawal of the drug results
in the loss of lck expression. The resulting lck-deficient T
cells show impaired homeostatic proliferation but normal
long-term survival and, surprisingly, normal levels of basal
CD3 
 


 
 phosphorylation (48). We asked whether loss of lck
expression was accompanied by a decrease of CD5 levels
on CD4 T cells and found a decrease to 
 

 
50% of the levels
in wild type mice, compared with 
 

 
80% in doxycycline-
fed mice (Fig. 3). We conclude that, in contrast to basal 
 


 
chain phosphorylation (48), the maintenance of CD5 levels
on peripheral CD4 T cells requires the continued expres-
sion of lck.
 
MHC Haplotype-specific Modulation of CD5 Levels.
 
The
data so far demonstrate that MHC contact and lck are re-
quired to sustain CD5 levels on naive peripheral CD4 T
cells but they do not distinguish between TCR and core-
ceptor involvement in the regulation of CD5 expression.
To approach this issue we made use of the fact that AND
TCR transgenic T cells are positively selected on A
 
b
 
 as well
as E
 
k
 
, the latter being considered to provide ‘stronger’ posi-
tive selection (41). We adopted an in vitro 3-D reaggregate
culture system (49) which allowed us to maintain naive
AND CD4 T cells in an environment manipulated to either
lack MHC expression or to express either of the two select-
ing MHC haplotypes, H-2
 
b
 
 or H-2
 
k
 
. Rag1
 
o/o
 
 H2
 
bxk
 
 AND
TCR transgenic naive CD4 LN cells were placed in re-
aggregate culture with a combination of thymic stroma cells
(depleted of endogenous lymphoid cells by treatment with
Figure 1. Loss of CD5 expression levels and basal tyrosine phosphory-
lation from naive CD4 LN cells maintained in vitro without TCR stimu-
lation. Suspension cultures of APC-depleted Rag1o/o AND TCR trans-
genic LN cells (see Materials and Methods) were analyzed (A) for
expression of TCR V3 (the AND  chain) and CD5 by flow cytometry
(histogram overlays are on a log scale and gated on CD4 cells) and (B)
for tyrosine phosphorylation status by Western blot analysis of total cell
lysates with anti phosphotyrosine mAb. Note the decline of CD5 and ty-
rosine phosphorylation levels over time.
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deoxyguanosine) and BM-derived APCs (39) prepared
from MHCo/o, H2b (C57BL/10), or H2k (B10.BR) mice.
3 d later, although most cells maintained their initial pheno-
typic characteristics, CD5 levels varied according to MHC
exposure. The lowest levels were evident on CD4 cells de-
prived of MHC interactions, intermediate levels on cells
maintained in an H-2b expressing environment, and the
highest levels on cells maintained in the presence of H-2k
(Fig. 4) (neither H2b thymic stroma nor H2b BM-derived
APCs on their own were able to sustain CD5 expression;
data not shown). Basal 
 chain phosphorylation was lost in
the absence of MHC, but maintained by either of the se-
lecting MHC haplotypes (Fig. 4). These data show that
CD5 expression by naive peripheral T cells is subject to
haplotype-specific regulation. As described previously for
the regulation of CD5 levels during thymocyte develop-
ment (19, 20), this result suggests an involvement of specific
TCR recognition over and above coreceptor engagement
in the regulation of CD5 expression by peripheral T cells.
Tuning CD4 T Cell Responsiveness by Environmental MHC
Class II Expression. As CD5 is implicated as a modifier of
lymphocyte receptor signaling (see Introduction) we were
interested in comparing the functional properties of naive
T cells expressing the same TCR but different levels of
CD5 as the result of environmental MHC exposure. To
this end, Rag1o/o AND LN CD4 T cells were placed in an
environment either devoid of MHC expression or express-
ing H-2k, using the 3-D reaggregate system described in
Fig. 4. After 3 d the cells were recovered and loaded with
the Ca2 indicator dye Fluo-4 to compare their respon-
siveness to TCR mediated stimuli. These were provided
either by subsaturating concentrations of anti-CD3 fol-
lowed by cross-linking (Fig. 5 top, cross-linking antibody
added at 0 s) or by contact with peptide-loaded BM-
derived APCs (Fig. 5, bottom). CD4 T cells that had been
deprived of MHC contact (and as a result displayed re-
duced CD5 levels, see Fig. 4) responded more vigorously
than cells from the same donor that had been maintained
in an MHC environment.
Polyclonal CD5low Naive CD4 T Cells Are Hyperresponsive
In Vitro but Less Effective at MHC-dependant Homeostatic Ex-
pansion than their CD5high Counterparts. To ask whether
CD5 expression levels are predictive of CD4 T cell respon-
siveness also in vivo, we separated polyclonal LN cells iso-
lated from wild-type mice into CD4CD44lowCD5low and
CD4CD44lowCD5high populations (Fig. 6 A) and com-
pared their responsiveness to anti-CD3 followed by cross-
linking (as in Fig. 5, top). The CD4CD44lowCD5low pop-
ulation responded to CD3 ligation slightly but consistently
better than CD4CD44lowCD5high cells as reflected in a
larger differential between resting and activated Ca2 levels
in CD5low cells (Fig. 6 B) and in a higher calculated fre-
quency of responding cells (Fig. 6 C).
Hence, as shown above for AND T cells deprived of
pMHC interactions, CD5 expression is predictive of re-
sponsiveness to anti-CD3 also in polyclonal naive CD4 T
cells. We performed adoptive transfer experiments to in-
vestigate the role of MHC interactions in the regulation of
Figure 2. Maintenance of CD5 expression levels on
naive peripheral CD4 T cells requires MHC contact.
107 APC-depleted Rag1o/o AND TCR transgenic LN
cells from A/ (bold) or A/o (thin line) donors
were transferred intravenously to Rag1o/o MHCo/o
hosts and host LN cells were analyzed for CD4, TCR
V11 (the AND  chain), and CD5 by flow cytometry
at the indicated times (histogram overlays are gated on
CD4 cells). 
Figure 3. Continued expression of lck is required for the maintenance
of CD5 levels on naive peripheral CD4 T cells. CD5 expression by CD4
T cells from C57Bl/10 (wild-type), Lck1/rtTA-C/lckneg mice given dox-
ycyclin, and Lck1/rtTA-C/lckneg mice taken off doxycyclin 12 wk earlier
were analyzed by flow cytometry.
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CD5 expression in polyclonal CD4 T cells and to compare
the ability of the CD44lowCD5low and CD44lowCD5high
subsets to proliferate in sublethally irradiated syngeneic
hosts or Rag-1o/o MHCo/o mice. As a test for their ability
to engage in productive interactions with syngeneic
pMHC ligands 30–32, 35) sorted CD4 CD44low CD5high
and CD5low populations of C57Bl/10 or Balb/c LN cells
were labeled with CFSE and transferred into sublethally
(450 rad) irradiated syngeneic hosts. 9–12 d after transfer
LN and spleens were recovered and donor cells identified
as CFSE CD4. Both populations had maintained their
initial CD5 levels (Table I). Analysis of cell division, quan-
titated as the dilution of CFSE, showed that only a minor-
ity of 20–25% of CD5high cells remained undivided
whereas in excess of 50% of CD5low cells had failed to di-
vide (Fig. 7, Table I). The observation that CD5low cells
Figure 4. Modulation of CD5
levels by environmental MHC
expression and haplotype. APC-
depleted Rag1o/o H2bxk AND
TCR transgenic LN cells were
placed in 3-D reaggregate cul-
ture with a combination of thy-
mic stroma and BM-derived
APCs (reference 39) prepared
from MHCo mice (thin line) or
from mice expressing one of two
selecting MHC haplotypes, H2b
(C57BL/10, bold line), or H2k
(B10.BR, dashed line). 3 d later
cell recovery was between 60
and 80% of input for all MHC
haplotypes (data not shown) and
cells were analyzed (A) for for-
ward scatter, CD4, CD45RB,
CD69, and CD5 expression by
flow cytometry (histogram over-
lays are gated on CD4 cells; the
brighter CD5 staining in this and subsequent figures is due to the use of PE-conjugated mAb instead of the FITC conjugates used in previous figures) and
(B) for tyrosine phosphorylation status by Western blot analysis of total cell lysates with anti-phosphotyrosine mAb. The blot was stripped and reprobed
for CD3 
 protein.
Figure 5. Tuning of naive CD4 T cell responsiveness by MHC contact. APC-depleted Rag1o/o Hk AND TCR transgenic LN cells were maintained
in 3-D reaggregate culture as in Fig. 4 either in an MHCo/o (black line) or H2k (B10.BR) environment (dashed line). After 3 d cells were loaded with the
Ca2 indicator Fluo-4 and stimulated with subsaturating concentrations of anti-CD3 followed by the addition of cross-linking antibody at 0 s (top) or
BM-derived APCs pulsed with the cognate pigeon cytochrome-C peptide 81–104 or the variant peptides K99R or K99A (bottom, the arrow indicates
centrifugation of the sample to provide T cell/APC contact, see Materials and Methods).
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proliferate poorly to syngeneic pMHC contact despite
their elevated responsiveness to CD3-mediated receptor li-
gation (Figs. 5 and 6) might at first seem counterintuitive
but is in fact predicted if, as suggested by the data in Figs. 2
and 4, low CD5 levels reflect poor self-pMHC interactions
(see Discussion). We controlled for the possibility that the
different rates of division after transfer into syngeneic hosts
were due to underlying differences in the proliferative
response of CD5high and CD5low naive CD4 T cells to
MHC-independent factors in highly lymphopenic hosts
(45, 46) by transfer of CD5high and CD5low naive CD4 T
cells into Rag-1o/o MHCo/o mice. In this setting both pop-
ulations responded with comparable rates of proliferation
and CD5 expression by both populations was reduced two
to threefold (Table I). Hence, deprivation from pMHC in-
teractions results in reduced CD5 expression in polyclonal
naive CD4 T cells. Consistent with a role for pMHC in-
teractions in regulating CD5 expression by naive poly-
clonal CD4 T cells, the CD5low fraction of the naive CD4
T cell repertoire has limited ability to interact productively
with syngeneic pMHC as measured by homeostatic prolif-
eration in syngeneic hosts.
Figure 6. Polyclonal CD5low CD4 LN
cells are hyperresponsive to CD3 ligation.
Freshly isolated polyclonal LN cells were
stained for CD4, CD5, and CD44 and sepa-
rated into CD4CD44lowCD5low and
CD4CD44lowCD5high populations by cell
sorting (A). LN cells were loaded with
Fluo-4, and incubated with subsaturating
concentrations of anti-CD3. Ca2 responses
were recorded immediately after cross-link-
ing. Response traces by CD4CD44low
CD5low (black line) and CD4CD44low
CD5high (dashed line) cells are overlayed for
comparison. Note the larger differential be-
tween resting and activated Ca2 levels in
CD5low cells (B) and the higher frequency
of responding cells within the in CD5low
population (C).
Table I. Cell Division and CD5 Expression after Adoptive 
Transfer into Sublethally Irradiated Syngeneic or Rag-1o/o
MHCo/o Hosts
Transferred
population Host
Percentage
undivided
mean  SD 
CD5
expression
mean  SD
n n
CD5low syngeneic 54.3 ± 9.8 (14) 333 ± 74 (13)
CD5high syngeneic 25.3 ± 10.8 (11) 1131± 165 (10)
CD5low Rag1o/o MHCo/o 25.5 ± 9.5 (3) 140 ± 27 (3)
CD5high Rag1o/o MHCo/o 23.1 ± 7.7 (3) 429 ± 116 (3)
Polyclonal LN cells were separated into CD4+CD44lowCD5low and
CD4+CD44lowCD5high populations, labeled with CFSE and 1–4  106
cells of each population were adoptively transferred either into 450 rad
irradiated (i.e., moderately lymphopenic) syngeneic, or into Rag-1o/o
MHCo/o (i.e., highly lymphopenic) hosts. Cell division and CD5 levels
were recorded 9–12 d later. Most CD4+CD44lowCD5low as well as
CD4+CD44lowCD5high cells undergo one or two cell divisions in Rag-
1o/o MHCo/o hosts, presumably driven by factors present in the highly
lymphopenic environment.
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Discussion
The data presented here show that CD5 levels on naive
peripheral CD4 T cells are maintained by an active process
which requires the availability of pMHC ligands on the
part of the environment and the continued expression of
p56lck on the part of the T cell. Reduced CD5 levels are
predictive of elevated Ca2 responses to TCR engagement
in TCR transgenic CD4 T cells experimentally deprived of
MHC contact as well as in unmanipulated polyclonal naive
CD4 T cell populations. Despite this elevated responsive-
ness to TCR engagement by the surrogate ligand anti-
CD3, naive polyclonal CD5low CD4 T cells proliferate
poorly when their interaction with self-pMHC is tested by
transfer into sublethally irradiated syngeneic hosts. As ho-
meostatic proliferation in this experimental setting is pro-
moted by pMHC recognition (30–32, 35) and we have
shown that naive CD4 T cells reduce CD5 expression
when experimentally deprived of MHC contact, the data
are consistent with a model where CD5 levels reflect pro-
ductive interactions with self-pMHC. Within a polyclonal
repertoire, some naive CD4 T cells will engage self pMHC
ligands more avidly than others. According to the model
presented in Fig. 8, the former become (or remain) CD5high
and display dampened Ca2 responses to anti-CD3 while
the latter become (or remain) CD5low and display elevated
Ca2 responses.
Gene targeting and overexpression studies implicate
CD5 as a negative regulator of lymphocyte receptor signal-
ing (see Introduction) but CD5 levels may not be the only
factor that modulates the responsiveness of naive CD4 T
cells deprived of or subjected to pMHC interactions. For
example, as a result of pMHC contact in vivo naive T cells
have partially phosphorylated CD3 
 chains (33, 50) which
can affect T cell activation (51), and this basal level of phos-
phorylation is reduced on MHC deprivation (references 33
and 50; this study). The dissociation between reduced CD5
levels and maintained CD3 
 phosphorylation in condi-
tionally lck-deficient CD4 T cells does not clarify this rela-
tionship since lck deficiency itself impairs T cell activation
(48). The cytoplasmic domain of CD5 has been shown to
interact not only with tyrosine phosphatase 1 (via an im-
munoreceptor tyrosine-based inhibitory motif around tyro-
sine residue 378) but also the protein kinases p56lck and
p59fyn as well as phosphatidylinositol (PI)3-K (via an im-
perfect immunoreceptor tyrosine-based activation motif
around tyrosine residues 429 and 441; references 10, 11,
13, and 16), indicating the potential for a more complex
role of CD5 in modulating lymphocyte receptor signaling.
Regardless of the mechanistic involvement of CD5, our re-
sults suggest that pMHC contact in peripheral lymphoid
organs, in addition to its role in T cell homeostasis, can
fine-tune T cell responsiveness (Fig. 8).
Receptor editing, receptor revision, and hypermutation
play important roles in B cell biology at the price of risk-
ing the loss of receptor expression due to nonproductive
Figure 7. Polyclonal CD5low CD4 LN cells show im-
paired MHC-dependent homeostatic expansion relative to
their CD5high counterparts. Polyclonal LN cells were sepa-
rated into CD4CD44lowCD5low and CD4CD44low
CD5high populations by cell sorting as in Fig. 6 A. After la-
beling with CFSE 1–4  106 cells of each population were
adoptively transferred into sublethally irradiated syngeneic
hosts. Proliferation was recorded as reduced CFSE fluores-
cence intensity 9 d later. Displays are gated on CD4
CFSE cells. The percentage of undivided cells is indi-
cated.
Figure 8. A model for sensory adaptation in naive CD4 T cells, illus-
trating the possible relationship between TCR engagement, CD5 expres-
sion, and responsiveness to TCR ligation. According to this model, naive
CD4 T cells that interact more strongly than others with self-pMHC ex-
press higher levels of CD5. Their responsiveness to subsequent TCR liga-
tion is dampened. The boundaries of the model remain to be defined. To
the left, persistent lack of pMHC interactions may result in the loss of the
cell from the naive peripheral T cell pool. To the right, excessive chronic
stimulation may be accompanied by the loss of the naive T cell phenotype
(reference 52).
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secondary rearrangements or the introduction of prema-
ture stop codons (52, 53). This provides a clear rationale
for the dependence of B cell survival on the continued ex-
pression of a functional BCR (54, 55). In mature T lineage
cells alterations of receptor expression occur rarely (56, 57)
and are of uncertain significance (52). Nevertheless, long-
term survival and homeostasis of naive peripheral T cells is
conditional to continued feedback through the TCR (24–
35). It is attractive to think that this requirement may be
more than evolutionary baggage carried by T cells on be-
half of their B cell relatives. If, as our results indicate,
pMHC contact continually modulates naive peripheral T
cell responsiveness, a requirement for such contact could
contribute to the maintenance of tolerance as suggested
earlier on theoretical grounds (58). Such a scenario would
extend the control of T cell responsiveness from thymic to
peripheral pMHC.
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